Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $1000.0.

  • Contineum Therapeutics' Amortizatization of Intangibles fell 9987.23% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 5683.77%. This contributed to the annual value of $3.9 million for FY2024, which is 4728.97% up from last year.
  • Contineum Therapeutics' Amortizatization of Intangibles amounted to $1000.0 in Q3 2025, which was down 9987.23% from $407000.0 recorded in Q2 2025.
  • In the past 5 years, Contineum Therapeutics' Amortizatization of Intangibles registered a high of $1.2 million during Q4 2023, and its lowest value of $1000.0 during Q3 2025.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $783000.0 (2024), whereas its average is $664363.6.
  • As far as peak fluctuations go, Contineum Therapeutics' Amortizatization of Intangibles soared by 38812.79% in 2024, and later crashed by 9987.23% in 2025.
  • Over the past 3 years, Contineum Therapeutics' Amortizatization of Intangibles (Quarter) stood at $1.2 million in 2023, then dropped by 11.1% to $1.1 million in 2024, then crashed by 99.91% to $1000.0 in 2025.
  • Its Amortizatization of Intangibles was $1000.0 in Q3 2025, compared to $407000.0 in Q2 2025 and $285000.0 in Q1 2025.